Qi Jinxing Net Worth

He is also the chairman of the Hangzhou Binjiang Investment Group, which is involved in the development of real estate, finance, and other industries. Qi Jinxing is a Japanese entrepreneur with a net worth of 1.4 billion. He is the chairman of Hangzhou Binjiang Real Estate Group and Hangzhou Binjiang Investment Group, which are involved in the development of real estate, finance, and other industries. His return to the billionaire circles in 2013 was due to the increase in real estate stocks in China and the success of his own new projects.
Qi Jinxing is a member of Richest Billionaires

Age, Biography and Wiki

Birth Year 1962
Birth Place Japan
Age 61 YEARS OLD
Net Worth: 1.4 billion

💰 Net worth: $1.49 Billion (2024)

Qi Jinxing Net Worth: Qi Jinxing is a Japanese entrepreneur who has a net worth of 1.4 billion. The chairman of Hangzhou Binjiang Real Estate Group, Qi Jinxing made a comeback to the billionaire circles in 2013, following a wide increase in real estate stocks in China and healthy sales of his own new projects. In the first nine months of 2012, he saw an incredible boost in the net worth of his Hangzhou Binjiang Real Estate Group, as it surged by 187% to $59.5 million, on sales that almost doubled reaching $308 million. To develop today's billion-dollar enterprise, Jinxing needed more than 19 years of devoted work. Initially, he had a job in a government district office and it was in 1996 when he turned down a bigger government position to establish Hangzhou Binjing Real Estate Group. The company, which has never ceased to grow, listed its shares at the Shenzhen Stock Exchange in May 2008. In recent times, the group declared its intention to build up business close to home in Hangzhou by purchasing two parcels of land in the tourist haven worth $267 million. Business aside, Qi Jinxing via his Hangzhou Binjiang Investment Holding backed cancer-treatment firm Ascletis, which formed a partnership with Nasdaq-listed Alnylam Pharmaceuticals last year in an attempt to develop drugs to fight liver cancer.